{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:03:38Z","timestamp":1767773018266,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ebiom.2020.103069","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T10:27:46Z","timestamp":1603448866000},"page":"103069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic"],"prefix":"10.1016","volume":"61","author":[{"given":"Luca","family":"Perico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobia","family":"Peracchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pezzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2020.103069_bib0001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ebiom.2020.103069_bib0002","unstructured":"EpiCentro. COVID-19 integrated surveillance: key national data. https:\/\/www.epicentro.iss.it\/en\/coronavirus\/sars-cov-2-integrated-surveillance-data (Accessed 25 September 2020)."},{"key":"10.1016\/j.ebiom.2020.103069_bib0003","unstructured":"COVID-19 ITALIA - Desktop. http:\/\/opendatadpc.maps.arcgis.com\/apps\/opsdashboard\/index.html#\/b0c68bce2cce478eaac82fe38d4138b1 (Accessed 25 September 2020)."},{"key":"10.1016\/j.ebiom.2020.103069_bib0004","unstructured":"Covid-19 Regione Lombardia. https:\/\/experience.arcgis.com\/experience\/0a5dfcc103d0468bbb6b14e713ec1e30\/ (Accessed 25 September 2020)."},{"issue":"10231","key":"10.1016\/j.ebiom.2020.103069_bib0005","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(20)30627-9","article-title":"COVID-19 and Italy: what next?","volume":"395","author":"Remuzzi","year":"2020","journal-title":"Lancet"},{"issue":"10253","key":"10.1016\/j.ebiom.2020.103069_bib0006","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S0140-6736(20)31865-1","article-title":"Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May 2020","volume":"396","author":"Alicandro","year":"2020","journal-title":"Lancet"},{"journal-title":"FDA","article-title":"Important Information on the Use of Serological (Antibody) Tests for COVID-19 - Letter to Health Care Providers","year":"2020","key":"10.1016\/j.ebiom.2020.103069_bib0007"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103069_bib0008","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.ebiom.2020.103069_bib0009","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/jama.2020.6170","article-title":"The Promise and Peril of Antibody Testing for COVID-19","volume":"323","author":"Abbasi","year":"2020","journal-title":"JAMA"},{"issue":"6497","key":"10.1016\/j.ebiom.2020.103069_bib0010","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.abc0473","article-title":"Rapid implementation of mobile technology for real-time epidemiology of COVID-19","volume":"368","author":"Drew","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.103069_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104394","article-title":"Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG","volume":"128","author":"Kr\u00fcttgen","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ebiom.2020.103069_bib0012","article-title":"IgG serology in health care and administrative staff populations from 7 hospital representative of different exposures to SARS-CoV-2 in Lombardy, Italy","author":"Sandri","year":"2020","journal-title":"medRxiv"},{"year":"1996","series-title":"Methods in observational epidemiology","author":"Kelsey","key":"10.1016\/j.ebiom.2020.103069_bib0013"},{"issue":"6","key":"10.1016\/j.ebiom.2020.103069_bib0014","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-020-03913-9","article-title":"Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards","volume":"39","author":"La Scola","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7809","key":"10.1016\/j.ebiom.2020.103069_bib0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.103069_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa638","article-title":"Predicting infectious SARS-CoV-2 from diagnostic samples","author":"Bullard","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2020.103069_bib0017","article-title":"Over Half of People in Mumbai's Slums Probably Infected With Coronavirus: survey","author":"Jamkh","year":"2020","journal-title":"The Wire Science"},{"key":"10.1016\/j.ebiom.2020.103069_bib0018","article-title":"The World Is Still Far From Herd Immunity for Coronavirus","author":"Popovich","year":"2020","journal-title":"The New York Times"},{"issue":"8","key":"10.1016\/j.ebiom.2020.103069_bib0019","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s41591-020-0949-6","article-title":"Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China","volume":"26","author":"Xu","year":"2020","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.ebiom.2020.103069_bib0020","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"7821","key":"10.1016\/j.ebiom.2020.103069_bib0021","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.103069_bib0022","article-title":"How deadly is COVID-19? A rigorous analysis of excess mortality and age-dependent fatality rates in Italy","author":"Modi","year":"2020","journal-title":"medRxiv"},{"journal-title":"Science Times","article-title":"Italy Nears Herd Immunity As Over Half of Its Covid-19 Epicenter's Population Tested Positive for Antibodies","year":"2020","key":"10.1016\/j.ebiom.2020.103069_bib0023"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103069_bib0024","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.immuni.2020.04.012","article-title":"Herd Immunity: understanding COVID-19","volume":"52","author":"Randolph","year":"2020","journal-title":"Immunity"},{"issue":"6493","key":"10.1016\/j.ebiom.2020.103069_bib0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.abb5793","article-title":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period","volume":"368","author":"Kissler","year":"2020","journal-title":"Science"},{"issue":"7813","key":"10.1016\/j.ebiom.2020.103069_bib0026","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/d41586-020-01738-2","article-title":"How deadly is the coronavirus? Scientists are close to an answer","volume":"582","author":"Mallapaty","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.103069_bib0027","article-title":"Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence","author":"Mehraeen","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ebiom.2020.103069_bib0028","article-title":"Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases","author":"Chavarria-Mir\u00f3","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ebiom.2020.103069_bib0029","article-title":"First detection of SARS-CoV-2 in untreated wastewaters in Italy","volume":"736","author":"Rosa","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.ebiom.2020.103069_bib0030","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2026116","article-title":"Humoral Immune Response to SARS-CoV-2 in Iceland","author":"Gudbjartsson","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ebiom.2020.103069_bib0031","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ebiom.2020.103069_bib0032","article-title":"Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection","author":"Seow","year":"2020","journal-title":"medRxiv"},{"issue":"11","key":"10.1016\/j.ebiom.2020.103069_bib0033","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1056\/NEJMc2025179","article-title":"Rapid Decay of Anti\u2013SARS-CoV-2 Antibodies in Persons with Mild Covid-19","volume":"383","author":"Ibarrondo","year":"2020","journal-title":"New England J. Medicine"},{"issue":"4","key":"10.1016\/j.ebiom.2020.103069_bib0034","doi-asserted-by":"crossref","first-page":"258","DOI":"10.37201\/req\/052.2020","article-title":"Utility of lateral flow tests in SARS-CoV-2 infection monitorization","volume":"33","author":"Candel","year":"2020","journal-title":"Rev Esp Quimioter"},{"issue":"8","key":"10.1016\/j.ebiom.2020.103069_bib0035","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cmi.2020.05.023","article-title":"Diagnostic performance of seven rapid IgG\/IgM antibody tests and the Euroimmun IgA\/IgG ELISA in COVID-19 patients","volume":"26","author":"Van Elslande","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ebiom.2020.103069_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104473","article-title":"Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: a prospective single-center study","volume":"129","author":"P\u00e9rez-Garc\u00eda","year":"2020","journal-title":"J Clin Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.103069_bib0037","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/diagnostics10050319","article-title":"Antibody Tests in Detecting SARS-CoV-2 Infection: a Meta-Analysis","volume":"10","author":"Kontou","year":"2020","journal-title":"Diagnostics"},{"issue":"10252","key":"10.1016\/j.ebiom.2020.103069_bib0038","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S0140-6736(20)31830-4","article-title":"Testing for responses to the wrong SARS-CoV-2 antigen","volume":"396","author":"Rosadas","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.103069_bib0039","unstructured":"KCDC. KCDC. KCDC. http:\/\/www.cdc.go.kr (Accessed 24 June 2020)."},{"issue":"8","key":"10.1016\/j.ebiom.2020.103069_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01068-20","article-title":"Culture-based virus isolation to evaluate potential infectivity of clinical specimens tested for COVID-19","volume":"58","author":"Huang","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ebiom.2020.103069_bib0041","article-title":"Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants","author":"van Kampen","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ebiom.2020.103069_bib0042","unstructured":"CDC. Coronavirus Disease 2019 (COVID-19). Centers for Disease Control and Prevention. 2020; https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/duration-isolation.html (Accessed 23 July 2020)."},{"key":"10.1016\/j.ebiom.2020.103069_bib0043","unstructured":"Criteria for releasing COVID-19 patients from isolation. https:\/\/www.who.int\/news-room\/commentaries\/detail\/criteria-for-releasing-covid-19-patients-from-isolation (Accessed 4 September , 2020)."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642030445X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235239642030445X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:04:13Z","timestamp":1762455853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235239642030445X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":43,"alternative-id":["S235239642030445X"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103069","relation":{},"ISSN":["2352-3964"],"issn-type":[{"type":"print","value":"2352-3964"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.103069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103069"}}